Lincocin Forte S
Introduction

Company name: Pfizer Limited
Address: Ramsgate Road
Sandwich
Kent CT13 9NJ
Telephone: 0845 300 8034 (Out of hours: 01304 616161)
Fax: 01737 332521
Email: UKVetLine@pfizer.com
Website: www.only4vets.co.uk
Presentation
Intramammary infusion: lactating cow.
Each 10 ml syringe contains lincomycin (as lincomycin hydrochloride) 330 mg and neomycin (as neomycin sulphate) 100 mg.
Uses
For the treatment of mastitis in lactating cattle. The product is effective against Staphylococcus species (both penicillinase and non-penicillinase producers) including Staphylococcus aureus, Streptococcus species including Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis, and coliform bacteria including Escherichia coli.
Dosage and administration
Dosage
Infuse one syringe (10 ml. product) into each affected quarter. Repeat this treatment immediately after each of the next two 12 hourly milkings, to give a total of three infusions per infected quarter.
Administration
By intramammary infusion only, taking aseptic precautions. The syringe must only be used once.
Where necessary, wash teats or whole udder thoroughly with warm water containing a suitable dairy disinfectant and dry them thoroughly. Milk out the udder completely. Disinfect teat end with a pad of alcohol or other suitable disinfectant. Use a separate pad for each teat. Remove cap from plastic tip. Choose the desired insertion length (full or partial) and insert the tip into the teat canal. Push plunger to dispense entire contents and massage the quarter to distribute the product into the milk cistern. Following infusion, it is advisable to dip all teats in an approved teat dip.
Contra-indications, warnings, etc
Withdrawal periods
Milk
Milk for human consumption may only be taken from 84 hours after the last treatment.
Meat
Animals must not be slaughtered for human consumption during treatment.
Treated animals may be slaughtered for human consumption only after 3 days following the last treatment.
Operator warning
Avoid contact with the solution. Wash hands and any exposed skin immediately after use.
This product should not be used concomitantly with macrolides e.g. erythromycin, because lincomycin and the macrolides antagonise each other at the site of action, the 50S ribosomal sub-unit.
For animal treatment only.
Any unused product or waste material should be disposed of in accordance with national requirements.
Pharmaceutical precautions
Do not store above 25°C. Protect from freezing. Protect from light.
Keep out of reach of children.
Legal category
POM-V
Packaging Quantities
24 × 10ml plastic syringes.
Further information
Nil.
Marketing authorisation number
Vm 00057/4249.